Companies in the therapeutics sector developing innovative solutions and technologies.
Explore 1,708 recently funded therapeutics companies with verified founder contact information and fundraising data.
IGM Biosciences is a biotechnology company that develops medicine for people with infectious infections, autoimmune diseases, and cancer.
Aeglea BioTherapeutics is a clinical-stage biotechnology company that develops enzyme therapies for rare metabolic diseases.
Pery is on a mission to build a better care model for children with ADHD and their families.
Syntax Bio is a biotechnology company that develops a cell programming platform to control stem cell differentiation for research.
AtG Therapeutics specializes in the development of therapeutic techniques for cancer resistance to improve the lives of cancer patients.
Carbon Biosciences is a biotech company that engages in the novel parvovirus gene therapy.
Inosi Therapeutics develop therapies to address fibrosis.
ProJenX is a biopharmaceutical company that develops novel small molecule therapeutics that target motor neuron degenerative pathways.
āshibio is a privately held biotechnology business exploring innovative therapies to treat bone and connective tissue ailments.
WellClarity is a specialty drug cost containment company that provides affordable access to high-cost medications.
Clivi is a specialized digital clinic that provides comprehensive treatment to patients with diabetes and obesity
Veralox Therapeutics develops small molecule therapeutics that treat the underlying pathologies of thrombosis and type one diabetes.
Replicate Bioscience develops self-replicating RNA therapeutics and vaccines delivering immunity at lower doses across multiple diseases.
AdaptVac is a joint-venture between ExpreS2ion Biotech and University of Copenhagen spin-out NextGen Vaccines.
Anoat Therapeutics develops an innovative, disease-modifying approach in Cystic Fibrosis.
One Biosciences leverages single-cell technologies to identify new therapeutics for difficult-to-treat diseases.
Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.
iQure Pharma is a global biotech company that develops new therapeutics for patients and physicians.
Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.
Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.
Cour Pharmaceuticals Development is developing nanoparticle technology to help reset the immune system of multiple sclerosis (MS) patients.
Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.
Draig Therapeutics is a clinical-stage biopharmaceutical startup.
Psyence develops natural psilocybin products for the treatment of psychological trauma and mental health disorders
The therapeutics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Therapeutics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The therapeutics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 1,708 therapeutics companies tracked in the VCBacked database.
Companies in the therapeutics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting therapeutics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked